Riggs Asset Managment Co. Inc. Sarepta Therapeutics, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $321 Million
- Q1 2025
A detailed history of Riggs Asset Managment Co. Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 2,300 shares of SRPT stock, worth $27,439. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,300
Previous 2,300
-0.0%
Holding current value
$27,439
Previous $279,000
47.67%
% of portfolio
0.05%
Previous 0.08%
Shares
8 transactions
Others Institutions Holding SRPT
# of Institutions
492Shares Held
89.8MCall Options Held
1.39MPut Options Held
1.11M-
Black Rock Inc. New York, NY10.3MShares$123 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$108 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$108 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$48.5 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$40.1 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.04B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...